Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Debt to Equity (2016 - 2025)

Phibro Animal Health has reported Debt to Equity over the past 13 years, most recently at $0.38 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.38 for Q4 2025, down 27.23% from a year ago — trailing twelve months through Dec 2025 was $0.38 (down 27.23% YoY), and the annual figure for FY2025 was $2.21, up 81.83%.
  • Debt to Equity for Q4 2025 was $0.38 at Phibro Animal Health, down from $2.01 in the prior quarter.
  • Over the last five years, Debt to Equity for PAHC hit a ceiling of $2.39 in Q1 2025 and a floor of $0.38 in Q4 2025.
  • Median Debt to Equity over the past 5 years was $1.09 (2022), compared with a mean of $1.09.
  • Biggest five-year swings in Debt to Equity: tumbled 59.83% in 2021 and later soared 179.29% in 2025.
  • Phibro Animal Health's Debt to Equity stood at $0.5 in 2021, then soared by 48.02% to $0.74 in 2022, then surged by 60.96% to $1.2 in 2023, then crashed by 55.88% to $0.53 in 2024, then decreased by 27.23% to $0.38 in 2025.
  • The last three reported values for Debt to Equity were $0.38 (Q4 2025), $2.01 (Q3 2025), and $2.21 (Q2 2025) per Business Quant data.